Abdel-Azim, H., Quigg, T., Kapoor, N., Chi, Y., Higham, C., Keating, A., Fabrizio, V., Skiles, J., Shenoy, S., Khazal, S., Gardenswartz, A., Madden, L., Milner, J., Phelan, R., Caywood, E., Duffner, U., Fish, J., Silva, J. G., Gillio, A., Hanna, R., Huo, J., Lalefar, N., Mahadeo, K., McNerney, K., Dolan, J. G., Salzberg, D., Stefanski, H., Pulsipher, M. (2025). High event-free (EFS) and overall survival (OS) after non-total body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL): Results from the EndRAD trial (PTCTC ONC1701). Blood. https://doi.org/10.1182/blood-2025-163